Neuronetics up 54% premarket on accelerated review status for NeuroStar [Seeking Alpha]
Neuronetics, Inc. (STIM)
Last neuronetics, inc. earnings: 3/3 06:00 am
Check Earnings Report
Company Research
Source: Seeking Alpha
Healthcare | On the Move Neuronetics up 54% premarket on accelerated review status for NeuroStar Mar. 6, 2020 7:44 AM ET Neuronetics, Inc. (STIM) Douglas W. House Thinly traded nano cap Neuronetics (NASDAQ: Breakthrough Device Designation The designation, akin to Breakthrough Therapy status for a drug, provides for more intensive guidance on development by the FDA, the involvement of more senior agency personnel, the assignment of a case manager and priority review of the marketing application. NeuroStar is a non-invasive transcranial magnetic stimulation device that creates a pulsed MRI-strength magnetic field that induces electrical currents that stimulate specific areas of the brain associated with mood. It was first cleared in the U.S. in 2008 for the treatment of adults with major depressive disorder who have not responded adequately to at least one antidepressant medicine. See all stocks on the move » Now read: Esperion's Approval, And Other News: The Good, Bad, And Ugly Of Bi
Show less
Read more
Impact Snapshot
Event Time:
STIM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STIM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STIM alerts
High impacting Neuronetics, Inc. news events
Weekly update
A roundup of the hottest topics
STIM
News
- Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month [Yahoo! Finance]Yahoo! Finance
- NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness MonthGlobeNewswire
- GREENBROOK TMS REPORTS FISCAL YEAR 2023 OPERATIONAL AND FINANCIAL RESULTS [Yahoo! Finance]Yahoo! Finance
- Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call [Yahoo! Finance]Yahoo! Finance
STIM
Earnings
- 3/5/24 - Beat
STIM
Sec Filings
- 4/11/24 - Form DEFA14A
- 4/11/24 - Form DEF
- 4/1/24 - Form SC
- STIM's page on the SEC website